Epstein-Barr virus induction of recombinase-activating genes RAG1 and RAG2.
作者信息
Srinivas S K, Sixbey J W
机构信息
Department of Infectious Diseases and Virology, St. Jude's Children's Research Hospital, Memphis, Tennessee 38101-0318, USA.
出版信息
J Virol. 1995 Dec;69(12):8155-8. doi: 10.1128/JVI.69.12.8155-8158.1995.
Abstract
In experimental B-cell infections, Epstein-Barr virus induced sustained expression of V(D)J recombinase-activating genes RAG1 and RAG2, whose aberrant activity has been implicated in chromosomal translocations in B-cell neoplasms. In cell lines in which RAG1 and RAG2 were detected, virus integrated into cellular DNA rather than assumed the configuration of extrachromosomal episomes. Expression of the Epstein-Barr virus nuclear antigen 1 in transient transfection assays was sufficient to induce both recombinase-activating genes.
摘要
相似文献
1
Epstein-Barr virus induction of recombinase-activating genes RAG1 and RAG2.
J Virol. 1995 Dec;69(12):8155-8. doi: 10.1128/JVI.69.12.8155-8158.1995.
2
DNA-binding studies of the Epstein-Barr virus nuclear antigen 2 (EBNA-2): evidence for complex formation by latent membrane protein gene promoter-binding proteins in EBNA-2-positive cell lines.
J Gen Virol. 1994 Nov;75 ( Pt 11):3067-79. doi: 10.1099/0022-1317-75-11-3067.
3
The Epstein-Barr virus latency BamHI-Q promoter is positively regulated by STATs and Zta interference with JAK/STAT activation leads to loss of BamHI-Q promoter activity.
Proc Natl Acad Sci U S A. 1999 Aug 3;96(16):9339-44. doi: 10.1073/pnas.96.16.9339.
4
Exclusive expression of Epstein-Barr virus nuclear antigen 1 in Burkitt lymphoma arises from a third promoter, distinct from the promoters used in latently infected lymphocytes.
Proc Natl Acad Sci U S A. 1991 Aug 1;88(15):6550-4. doi: 10.1073/pnas.88.15.6550.
5
Expression of the chemokine receptor BLR2/EBI1 is specifically transactivated by Epstein-Barr virus nuclear antigen 2.
Biochem Biophys Res Commun. 1995 Oct 13;215(2):737-43. doi: 10.1006/bbrc.1995.2525.
6
Epstein-Barr virus EBNA3A and EBNA3C proteins both repress RBP-J kappa-EBNA2-activated transcription by inhibiting the binding of RBP-J kappa to DNA.
J Virol. 1996 Sep;70(9):5909-15. doi: 10.1128/JVI.70.9.5909-5915.1996.
7
The EBNA-2 arginine-glycine domain is critical but not essential for B-lymphocyte growth transformation; the rest of region 3 lacks essential interactive domains.
J Virol. 1994 Oct;68(10):6188-97. doi: 10.1128/JVI.68.10.6188-6197.1994.
8
Methylation of discrete sites within the enhancer region regulates the activity of the Epstein-Barr virus BamHI W promoter in Burkitt lymphoma lines.
J Virol. 1992 Jan;66(1):62-9. doi: 10.1128/JVI.66.1.62-69.1992.
9
Analysis of viral gene expression and genome persistence in CD23-positive and -negative subpopulations of Epstein-Barr-virus-infected BL2 cells.
Intervirology. 1994;37(5):236-44. doi: 10.1159/000150384.
10
The amino-terminal domains of Epstein-Barr virus nuclear proteins 3A, 3B, and 3C interact with RBPJ(kappa).
J Virol. 1996 May;70(5):3068-74. doi: 10.1128/JVI.70.5.3068-3074.1996.
引用本文的文献
1
The Epstein-Barr Virus-Encoded EBNA1 Protein Activates the Bone Morphogenic Protein (BMP) Signalling Pathway to Promote Carcinoma Cell Migration.
Pathogens. 2020 Jul 21;9(7):594. doi: 10.3390/pathogens9070594.
2
KSHV induces immunoglobulin rearrangements in mature B lymphocytes.
PLoS Pathog. 2018 Apr 16;14(4):e1006967. doi: 10.1371/journal.ppat.1006967. eCollection 2018 Apr.
3
Similarities between the Epstein-Barr Virus (EBV) Nuclear Protein EBNA1 and the Pioneer Transcription Factor FoxA: Is EBNA1 a "Bookmarking" Oncoprotein that Alters the Host Cell Epigenotype?
Pathogens. 2012 Sep 17;1(1):37-51. doi: 10.3390/pathogens1010037.
4
A Role for RNA Viruses in the Pathogenesis of Burkitt's Lymphoma: The Need for Reappraisal.
Adv Hematol. 2012;2012:494758. doi: 10.1155/2012/494758. Epub 2011 Nov 29.
5
Epstein-Barr virus-encoded EBNA1 inhibits the canonical NF-kappaB pathway in carcinoma cells by inhibiting IKK phosphorylation.
Mol Cancer. 2010 Jan 5;9:1. doi: 10.1186/1476-4598-9-1.
6
Paleo-immunology: evidence consistent with insertion of a primordial herpes virus-like element in the origins of acquired immunity.
PLoS One. 2009 Jun 3;4(6):e5778. doi: 10.1371/journal.pone.0005778.
7
Is the Epstein-Barr virus EBNA-1 protein an oncogen?
Proc Natl Acad Sci U S A. 2009 Feb 17;106(7):2091-2. doi: 10.1073/pnas.0812575106. Epub 2009 Feb 11.
8
Rhesus lymphocryptovirus type 1-associated B-cell nasal lymphoma in SIV-infected rhesus macaques.
Vet Pathol. 2008 Nov;45(6):914-21. doi: 10.1354/vp.45-6-914.
9
Mechanisms involved in Burkitt's tumor formation.
Clin Transl Oncol. 2008 May;10(5):250-5. doi: 10.1007/s12094-008-0193-x.
10
The EBV nuclear antigen 1 (EBNA1) enhances B cell immortalization several thousandfold.
Proc Natl Acad Sci U S A. 2003 Sep 16;100(19):10989-94. doi: 10.1073/pnas.1832776100. Epub 2003 Aug 28.
本文引用的文献
1
Epstein-Barr virus nuclear proteins EBNA-3A and EBNA-3C are essential for B-lymphocyte growth transformation.
J Virol. 1993 Apr;67(4):2014-25. doi: 10.1128/JVI.67.4.2014-2025.1993.
2
Topoisomerase I and II activities are required for Epstein-Barr virus replication.
J Gen Virol. 1993 Oct;74 ( Pt 10):2263-8. doi: 10.1099/0022-1317-74-10-2263.
3
Association between the p170 form of human topoisomerase II and progeny viral DNA in cells infected with herpes simplex virus type 1.
J Virol. 1994 Feb;68(2):1010-20. doi: 10.1128/JVI.68.2.1010-1020.1994.
4
Cell cycle regulation of V(D)J recombination-activating protein RAG-2.
Proc Natl Acad Sci U S A. 1994 Mar 29;91(7):2733-7. doi: 10.1073/pnas.91.7.2733.
5
BCL2 translocation frequency rises with age in humans.
Proc Natl Acad Sci U S A. 1994 Sep 13;91(19):8910-4. doi: 10.1073/pnas.91.19.8910.
6
Autoantigenic proteins that bind recombinogenic sequences in Epstein-Barr virus and cellular DNA.
Proc Natl Acad Sci U S A. 1994 Aug 30;91(18):8646-50. doi: 10.1073/pnas.91.18.8646.
7
The association of Epstein-Barr virus with smooth-muscle tumors occurring after organ transplantation.
N Engl J Med. 1995 Jan 5;332(1):19-25. doi: 10.1056/NEJM199501053320104.
8
Expression of recombination activating genes (RAG-1 and RAG-2) in Epstein-Barr virus-bearing B cells.
Blood. 1995 Mar 1;85(5):1289-99.
9
Epstein-Barr virus coinfection and recombination in non-human immunodeficiency virus-associated oral hairy leukoplakia.
J Infect Dis. 1995 May;171(5):1122-30. doi: 10.1093/infdis/171.5.1122.
10
Epstein-Barr virus nuclear antigen 3C is a transcriptional regulator.
J Virol. 1995 Jun;69(6):3624-30. doi: 10.1128/JVI.69.6.3624-3630.1995.
Zotero 插件